Inventor · disambiguated record
Dan T. Stinchcomb
Also filed as: STINCHCOMB DAN · STINCHCOMB DAN T · STINCHCOMB DAN THOMAS
57 granted patents·18 pending applications·1,381 citations·filing 1994–2024
99Inventor score
Top patents by PatentIndex Score
75 records- 0198US5972704AHIV nef targeted ribozymesRIBOZYME PHARM INC·Filed 1997·Granted Oct 26, 1999·221 cites·22 claims
- 0297US11192941B2Multi-valent human immunodeficiency virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2020·Granted Dec 7, 2021·4 cites·20 claims
- 0396US6566127B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorRIBOZYME PHARM INC·Filed 1999·Granted May 20, 2003·141 cites·5 claims
- 0495US7034009B2Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)CHIRON CORP·Filed 2002·Granted Apr 25, 2006·49 cites·20 claims
- 0595US5877022ARibozymes targeted to APO(a) RNARIBOZYME PHARM INC·Filed 1996·Granted Mar 2, 1999·167 cites·20 claims
- 0693US5646042AC-myb targeted ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Jul 8, 1997·123 cites·220 claims
- 0791US5877021AB7-1 targeted ribozymesRIBOZYME PHARM INC·Filed 1996·Granted Mar 2, 1999·88 cites·11 claims
- 0890US8084039B2Methods and compositions for live attenuated virusesSTINCHCOMB DAN T·Filed 2008·Granted Dec 27, 2011·15 cites·30 claims
- 0990US2025018006A1Compositions and Methods for Dengue Virus Chimeric Constructions in VaccinesTAKEDA VACCINES INC·Filed 2024·Application pending·0 cites
- 1089US10570191B2Multi-valent human immunodeficiency virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2016·Granted Feb 25, 2020·7 cites·14 claims
- 1187US5811300ATNF-α ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Sep 22, 1998·95 cites·13 claims
- 1286US8968996B2Compositions and methods for rapid immunization against dengue virusSTINCHCOMB DAN T·Filed 2012·Granted Mar 3, 2015·5 cites·14 claims
- 1385US6410224B1Ribozyme treatment of diseases or conditions related to levels of NF-κBRIBOZYME PHARM INC·Filed 1996·Granted Jun 25, 2002·48 cites·4 claims
- 1485US5731295AMethod of reducing stromelysin RNA via ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Mar 24, 1998·59 cites·2 claims
- 1585US5693535AHIV targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Dec 2, 1997·84 cites·100 claims
- 1684US11931399B2Compositions and methods for dengue virus chimeric constructions in vaccinesTAKEDA VACCINES INC·Filed 2022·Granted Mar 19, 2024·0 cites·29 claims
- 1784US9834757B2Hand, foot, and mouth vaccines and methods of manufacture and use thereofTAKEDA VACCINES INC·Filed 2015·Granted Dec 5, 2017·2 cites·20 claims
- 1884US8871487B2Compositions, methods and uses for inducing viral growthSTINCHCOMB DAN T·Filed 2009·Granted Oct 28, 2014·6 cites·20 claims
- 1984US7314627B2Cationic lipid-mediated enhancement of nucleic acid immunization of catsHESKA CORP·Filed 2004·Granted Jan 1, 2008·12 cites·2 claims
- 2082US9713638B2Compositions and methods for rapid immunization against dengue virusTAKEDA VACCINES INC·Filed 2013·Granted Jul 25, 2017·2 cites·16 claims
- 2182US6506784B1Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticidesDIMENSIONAL PHARM INC·Filed 2000·Granted Jan 14, 2003·14 cites·17 claims
- 2282US6194150B1Nucleic acid based inhibition of CD40RIBOZYME PHARM INC·Filed 1998·Granted Feb 27, 2001·45 cites·26 claims
- 2380US6518266B11- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticidesDIMENSIONAL PHARMACEUTICALS 3·Filed 2000·Granted Feb 11, 2003·17 cites·41 claims
- 2479US12186363B2Compositions and methods for dengue virus chimeric constructions in vaccinesTAKEDA VACCINES INC·Filed 2021·Granted Jan 7, 2025·0 cites·30 claims
- 2579US10052374B2Compositions, methods and uses for dengue virus serotype-4 constructsTAKEDA VACCINES INC·Filed 2016·Granted Aug 21, 2018·2 cites·25 claims
- 2679US9783579B2Compositions and methods for dengue virus chimeric constructs in vaccinesSTINCHCOMB DAN T·Filed 2014·Granted Oct 10, 2017·2 cites·11 claims
- 2777US9211323B2Compositions and methods for administration of vaccines against dengue virusSTINCHCOMB DAN T·Filed 2010·Granted Dec 15, 2015·4 cites·19 claims
- 2874US10525120B2Methods and compositions for live attenuated virusesTAKEDA VACCINES INC·Filed 2016·Granted Jan 7, 2020·1 cites·14 claims
- 2974US10233429B2Hand, foot, and mouth vaccines and methods of manufacture and use thereofTAKEDA VACCINES INC·Filed 2017·Granted Mar 19, 2019·1 cites·19 claims
- 3074US6436644B1Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (CAM-1)RIBOZYME PHARM INC·Filed 2000·Granted Aug 20, 2002·2 cites·19 claims
- 3173US8029776B2Cationic lipid-mediated enhancement of nucleic acid immunization of catsHESKA CORP·Filed 2007·Granted Oct 4, 2011·0 cites·16 claims
- 3272US9890362B2Compositions, methods and uses for inducing viral growthTAKEDA VACCINES INC·Filed 2014·Granted Feb 13, 2018·1 cites·45 claims
- 3370US8088903B2Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereofBRANDT KEVIN S·Filed 2006·Granted Jan 3, 2012·1 cites·3 claims
- 3469US10010600B2Compositions and methods for administration of vaccines against dengue virusTAKEDA VACCINES INC·Filed 2015·Granted Jul 3, 2018·1 cites·15 claims
- 3568US11197923B2Methods and compositions for live attenuated virusesTAKEDA VACCINES INC·Filed 2019·Granted Dec 14, 2021·0 cites·26 claims
- 3668US5837542AIntercellular adhesion molecule-1 (ICAM-1) ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Nov 17, 1998·20 cites·13 claims
- 3768US2020061151A1Compositions and Methods for Dengue Virus Chimeric Constructs in VaccinesTAKEDA VACCINES INC·Filed 2019·Application pending·0 cites
- 3867US10898565B2Compositions, methods and uses for dengue virus serotype-4 constructsTAKEDA VACCINES INC·Filed 2018·Granted Jan 26, 2021·0 cites·17 claims
- 3967US10806781B2Compositions and methods for live, attenuated alphavirus formulationsTAKEDA VACCINES INC·Filed 2018·Granted Oct 20, 2020·0 cites·15 claims
- 4067US9408901B2Compositions, methods and uses for dengue virus serotype-4 constructsINVIRAGEN INC·Filed 2013·Granted Aug 9, 2016·2 cites·27 claims
- 4167US5612215AStromelysin targeted ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Mar 18, 1997·19 cites·166 claims
- 4267US2009170197A1Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)SIRNA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 4366US5807743AInterleukin-2 receptor gamma-chain ribozymesRIBOZYME PHARM INC·Filed 1996·Granted Sep 15, 1998·18 cites·15 claims
- 4466US5616488AIL-5 targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Apr 1, 1997·23 cites·22 claims
- 4565US10449231B2Compositions and methods for dengue virus chimeric constructs in vaccinesTAKEDA VACCINES INC·Filed 2017·Granted Oct 22, 2019·0 cites·14 claims
- 4662US5658780ARel a targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Aug 19, 1997·14 cites·13 claims
- 4761US5705388ACETP RibozymesRIBOZYME PHARM INC·Filed 1994·Granted Jan 6, 1998·15 cites·14 claims
- 4860US2018008691A1Compositions and methods for rapid immunization against dengue virusTAKEDA VACCINES INC·Filed 2017·Application pending·0 cites
- 4959US6103890AEnzymatic nucleic acids that cleave C-fosRIBOZYME PHARM INC·Filed 1997·Granted Aug 15, 2000·12 cites·19 claims
- 5058US10137186B2Compositions and methods for live, attenuated alphavirus formulationsTAKEDA VACCINES INC·Filed 2014·Granted Nov 27, 2018·0 cites·15 claims
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dan T. Stinchcomb files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →